Biotinylated Human CD8 alpha&beta (CD8A&CD8B) Heterodimer Protein, His,Avitag™&Tag Free (MALS verified)

製品番号/仕様
価格
数量
CDA-H82W7-25ug
$435.00
CDA-H82W7-200ug (100ug X 2)
$1880.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    CD8 alpha & beta, CD8A & CD8B

  • Source

    Biotinylated Human CD8A&CD8B Heterodimer Protein, His,Avitag&Tag Free (CDA-H82W7) is expressed from human 293 cells (HEK293). It contains AA Ser 22 - Asp 182 & Leu 22 - Pro 170 (Accession # P01732 & P10966-1).

    Predicted N-terminus: Ser 22 & Leu 22

    Request for sequence
  • Molecular Characterization

    CD8 alpha & beta Structure

    Other Tags and Version Biotin & Other Labeled Version

    Biotinylated Human CD8A&CD8B Heterodimer Protein, His,Avitag&Tag Free, produced by co-expression of CD8 alpha and CD8 beta, has a calculated MW of 26.0 kDa (CD8 alpha) and 22.1 kDa (CD8 beta). Subunit CD8 alpha is fused with a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™) and subunit CD8 beta contains no tag at the C-terminus. The protein migrates as 33 kDa and 35 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Endotoxin

    Less than 0.1 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    CD8 alpha & beta SDS-PAGE

    Biotinylated Human CD8A&CD8B Heterodimer Protein, His,Avitag&Tag Free on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    CD8 alpha & beta SEC-MALS

    The purity of Biotinylated Human CD8A&CD8B Heterodimer Protein, His,Avitag&Tag Free (Cat. No. CDA-H82W7) is more than 90% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     CD8 alpha & beta ELISA

    Immobilized Biotinylated Human CD8A&CD8B Heterodimer Protein, His,Avitag&Tag Free (Cat. No. CDA-H82W7) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-CD8 alpha Antibody, Human IgG1 with a linear range of 0.1-1 ng/mL (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. CD8A forms disulfide-linked heterodimers with CD8B at the cell surface. CD8A homodimer molecules also promote the survival and differentiation of activated lymphocytes into memory CD8 T-cells. Additionally, CD8B plays a critical role in thymic selection of CD8+ T-cells. A palmitoylation site in the cytoplasmic tail of CD8B chain contributes to partitioning of CD8 into the plasma membrane lipid rafts where signaling proteins are enriched.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    T-cell surface glycoprotein CD8 beta chain

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    0 詳細

  • 最新の開発ステージ:

    Preclinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8